There seems little doubt that alpha-adrenergic blockers can afford a measure of relief to
many sufferers from BPH. The exact role this treatment has to play in the overall
management of these patients has yet to be clearly defined. A continuing search is being
made for more effective drugs, with the hope of finding one that will be more specific in its
action on the prostate and produce fewer generalized effects. Whether this will prove
possible may depend on whether any further subgroup of alpha receptors more specific to …